Lind Kevin Robert Stock Option Grant

On June 30, 2026, Kevin Robert Lind, a director at Avalo Therapeutics, Inc. (AVTX), was granted 1105 stock options to purchase common stock at a price of $15.04 per share. These options are immediately 100% vested and have an exercise price of $18.48. The options have an expiration date of June 30, 2036. This transaction is reported on Form 4, filed on July 2, 2026.